Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-116711)

Filing Details

Accession Number:: 0001144204-16-116711
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-04 21:42:08
Reporting Period:: 2016-08-04

Filing Date:: 2016-08-04
Accepted Time:: 2016-08-04 21:42:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1208261	Immune Pharmaceuticals Inc	IMNP	Pharmaceutical Preparations (2834)	521841431

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1584822	Gedeon Daniel Teper	C/O Immune Pharmaceuticals Inc. 430 East 29Th Street, Suite 940 New York NY 10016	Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-04	937,500	$0.38	5,748,405	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Acquisiton	2016-06-24	300,000	$0.00	300,000	$0.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,546,751		2026-06-24	No	4	A	Direct

Footnotes

Shares issued upon repayment of a $356,250 promissory note at the conversion price of $0.38 per share.
The stock options shall vest immediately on the date of grant.